Related Experiment Video
Updated: Apr 19, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
Applications of nanoparticles in treatment and diagnosis of leukemia
Govind Soni1, Khushwant S Yadav1
1Department of Pharmaceutics, Rajeev Gandhi College of Pharmacy, Salaiya, Via Danish Kunj, Kolar Road, Bhopal, 462042 M.P., India.
Abstract:
The conventional chemotherapy for leukemia involves frequent dosing, severe side effects and lack of specificity of such anticancer drugs. The treatment with most of the anti-leukemic drugs would be improved if they were delivered to their biological targets through appropriate application of nanotechnology by manipulating at the molecular level. Nanoparticles in the recent years have shown tremendous application with respect to diagnosis and treatment of leukemia. The review specifically focuses on the use of nanoparticles for sustaining the release of anti-leukemic drugs and intracellular delivery of such nanoparticles. The review also highlights the application of nanoparticles in reversal of multidrug resistance.

